"Pregnancy and Lactation Associated Osteoporosis"

Area of Science:

• Obstetrics and Gynecology
• Endocrinology
• Orthopedics

Background:

• Pregnancy-associated osteoporosis (PAO) is a rare condition causing skeletal fragility during pregnancy or postpartum.
• Physiological changes in calcium metabolism during pregnancy, though usually reversible, can lead to osteoporosis in a subset of women.
• Vertebral fractures are common and often multiple in PAO, highlighting the severity of skeletal compromise.

Purpose of the Study:

• To review the current understanding of pregnancy-associated osteoporosis.
• To discuss the potential aetiologies, including genetic and metabolic factors.
• To explore the challenges in managing PAO and the limited evidence for available treatments.

Main Methods:

• Literature review of existing studies on pregnancy-associated osteoporosis.
• Analysis of case reports and small studies due to the rarity of the condition.
• Synthesis of information on calcium metabolism, skeletal physiology, and fracture patterns in PAO.

Main Results:

• PAO is characterized by skeletal fragility and fractures, predominantly vertebral.
• The aetiology of PAO is not well understood, with potential contributions from genetic and traditional osteoporosis risk factors.
• Existing treatments like bisphosphonates, denosumab, and teriparatide have limited supporting data for PAO.

Conclusions:

• Pregnancy-associated osteoporosis is a rare but serious condition requiring further research.
• Understanding the underlying causes is crucial for effective management strategies.
• More evidence-based treatment guidelines are needed for this challenging condition.